REVIEW
Accepted on 30 Jul 2025
TP53-Mutated MDS and AML: Immune Dysregulation, Tumor Microenvironment, and Emerging Therapeutic Strategies
doi 10.3389/fonc.2025.1655486
- 148 views
1,651
Total downloads
8,950
Total views and downloads
Submit your idea
You will be redirected to our submission process.
REVIEW
Accepted on 30 Jul 2025
CASE REPORT
Accepted on 30 Jul 2025
ORIGINAL RESEARCH
Published on 30 Jul 2025
CASE REPORT
Published on 23 Jul 2025
CASE REPORT
Published on 21 Jul 2025
ORIGINAL RESEARCH
Published on 08 May 2025
CASE REPORT
Published on 04 Apr 2025
BRIEF RESEARCH REPORT
Published on 02 Apr 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.